We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$31.3M
Cap. Flow
+$2.28M
Cap. Flow %
1.84%
Top 10 Hldgs %
30.99%
Holding
124
New
34
Increased
26
Reduced
39
Closed
14
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
UBX icon
Unity Biotechnology
UBX
+$4.51M
2
SPOT icon
Spotify
SPOT
+$1.47M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$1.31M
4
CNC icon
Centene
CNC
+$1.21M
5
APTX
Aptinyx Inc. Common Stock
APTX
+$1.17M

Top Sells

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$4M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.52M
3
MSFT icon
Microsoft
MSFT
+$2.51M
4
BAX icon
Baxter International
BAX
+$1.81M
5
BOX icon
Box
BOX
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 50.9%
2 Miscellaneous 19.79%
3 Technology 12.71%
4 Communication Services 9.85%
5 Consumer Discretionary 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$487B
$9.05M 7.31%
+52,700
New +$8.84M
2018 Q2
0 quarters
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$77.5B
$4.55M 3.68%
+27,800
New +$4.45M
2018 Q2
0 quarters
UBX icon
3
DELISTED
Unity Biotechnology
UBX
$4.08M 3.29%
+30,876
New +$4.51M
2018 Q2
0 quarters
ALNA
4
DELISTED
Allena Pharmaceuticals
ALNA
$3.88M 3.14%
298,005
-277,402
-48% -$4M
2017 Q4
2 quarters
ELV icon
5
Elevance Health
ELV
$92.9B
$3.41M 2.76%
14,344
+591
+4% +$137K
2016 Q4
6 quarters
JAZZ icon
6
Jazz Pharmaceuticals
JAZZ
$13.9B
$2.99M 2.41%
17,334
+1,796
+12% +$294K
2018 Q1
1 quarter
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$4.27T
$2.68M 2.17%
47,480
+20,560
+76% +$1.12M
2017 Q2
4 quarters
CRM icon
8
Salesforce
CRM
$203B
$2.61M 2.11%
19,153
+4,770
+33% +$609K
2017 Q2
4 quarters
PTLA
9
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.6M 2.1%
68,808
-3,476
-5% -$133K
2016 Q4
6 quarters
VTRS icon
10
Viatris
VTRS
$20.9B
$2.52M 2.04%
69,879
-4,971
-7% -$195K
2018 Q1
1 quarter
BIDU icon
11
Baidu
BIDU
$28.1B
$2.37M 1.91%
9,738
+3,769
+63% +$938K
2017 Q4
2 quarters
AERI
12
DELISTED
Aerie Pharmaceuticals
AERI
$2.34M 1.89%
34,580
-1,891
-5% -$106K
2015 Q1
13 quarters
EEM icon
13
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.6B
$2.19M 1.77%
+50,500
New +$2.34M
2018 Q2
0 quarters
THC icon
14
Tenet Healthcare
THC
$22.2B
$2.1M 1.69%
62,424
+12,610
+25% +$392K
2018 Q1
1 quarter
BABA icon
15
Alibaba
BABA
$276B
$1.95M 1.58%
10,529
+3,307
+46% +$630K
2017 Q1
5 quarters
ZBH icon
16
Zimmer Biomet
ZBH
$18B
$1.92M 1.55%
17,725
-1,433
-7% -$156K
2017 Q4
2 quarters
HUM icon
17
Humana
HUM
$51.9B
$1.84M 1.49%
6,185
-553
-8% -$162K
2016 Q3
7 quarters
GDDY icon
18
GoDaddy
GDDY
$13.6B
$1.81M 1.46%
25,653
-7,985
-24% -$543K
2016 Q4
6 quarters
ABT icon
19
Abbott
ABT
$181B
$1.65M 1.33%
27,034
-9,881
-27% -$599K
2017 Q2
4 quarters
INTU icon
20
Intuit
INTU
$88.2B
$1.61M 1.3%
7,889
+1,612
+26% +$309K
2018 Q1
1 quarter
DATA
21
DELISTED
Tableau Software, Inc.
DATA
$1.54M 1.25%
15,800
-5,086
-24% -$466K
2018 Q1
1 quarter
SPOT icon
22
Spotify
SPOT
$110B
$1.54M 1.25%
+9,164
New +$1.47M
2018 Q2
0 quarters
UNH icon
23
UnitedHealth
UNH
$365B
$1.49M 1.2%
6,055
-4,612
-43% -$1.11M
2016 Q2
8 quarters
EW icon
24
Edwards Lifesciences
EW
$50.8B
$1.48M 1.2%
30,552
-4,518
-13% -$211K
2014 Q4
14 quarters
PBYI icon
25
Puma Biotechnology
PBYI
$543M
$1.4M 1.13%
23,694
-3,460
-13% -$201K
2016 Q4
6 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Partner Investment Management held 124 positions worth $124M, up 34% from $92.6M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Partner Investment Management's Q2 2018 filing shows 34 new, 26 increased, 39 reduced and 14 closed positions. Its largest new stake was Unity Biotechnology: 30,876 shares worth $4.08M. The largest sale was Allena Pharmaceuticals, an estimated $4M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Technology.

  • Partner Investment Management's largest Q2 2018 buy was Unity Biotechnology: 30,876 shares worth $4.08M.
  • Partner Investment Management added most to Alphabet (Google) Class A in Q2 2018, an estimated $1.12M increase.
  • Partner Investment Management's biggest Q2 2018 reduction was Allena Pharmaceuticals, cutting an estimated $4M.
  • Partner Investment Management fully exited Bristol-Myers Squibb in Q2 2018, selling an estimated $3.52M.
  • Partner Investment Management's ten largest holdings make up 31% of its $124M portfolio in Q2 2018.
  • Partner Investment Management opened 34 new positions and closed 14 in Q2 2018.
  • Partner Investment Management's portfolio value rose 34% quarter-over-quarter to $124M.

Based on Partner Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.